... OXGENE, a pioneering UK-based contract research and development organization that designs and develops scalable gene therapy technologies.
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/article/wuxi-apptec-buys-uk-crdo-firm-for-135-million&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFLGmHP-fbzq5KkXlylzVG_i-2FHw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.